Ann: AFP builds North American momentum, page-3

I believe that they are the market leader in Australia for this type of product tho and no-one else has the hospital IV formulation. Internationally, they are the only one of these type of products approved across all of Europe [company said].

Sales growth is reported to rely upon Australian sales growth where they have a diversified portfolio of products and also growth of International sales.

Interestingly tho, Asia sales doubled last year as well and a T-Mall site has also been opened to start to grow business into China

Simply Wall St has them valued at over $10 so seems a range of valuations. Guess time will tell